Home workouts aim to fight fatigue in breast cancer drug trial

NCT ID NCT07203378

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times

Summary

This study tests whether a 12-week, home-based exercise program (aerobic and resistance training) can reduce cancer-related fatigue in people with metastatic breast cancer who are taking the drug Enhertu. About 80 participants will follow an unsupervised workout routine. The goal is to see if exercise can improve energy and quality of life during treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Huntsman Cancer Institute at University of Utah

    RECRUITING

    Salt Lake City, Utah, 84112, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.